Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
8.20
-0.37 (-4.32%)
Jan 2, 2025, 4:00 PM EST - Market closed

Champions Oncology Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019 - 2015
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2019 - 2015
Market Capitalization
112666710414492
Upgrade
Market Cap Growth
-27.78%-1.17%-35.77%-27.72%56.56%-12.98%
Upgrade
Enterprise Value
116696410514392
Upgrade
Last Close Price
8.574.854.927.6810.737.72
Upgrade
PE Ratio
---189.51396.90-
Upgrade
Forward PE
43.16--42.9577.3177.20
Upgrade
PS Ratio
2.171.311.242.113.502.86
Upgrade
PB Ratio
172.39-34.6514.3911.4219.3418.00
Upgrade
P/TBV Ratio
153.62-15.5111.8520.2619.26
Upgrade
P/FCF Ratio
--60.6425.25-133.97
Upgrade
P/OCF Ratio
--16.7915.98-31.59
Upgrade
PEG Ratio
---2.865.445.15
Upgrade
EV/Sales Ratio
2.161.381.192.133.482.88
Upgrade
EV/EBITDA Ratio
80.62--46.9092.05-
Upgrade
EV/EBIT Ratio
---172.62389.82-
Upgrade
EV/FCF Ratio
--58.1225.48-134.98
Upgrade
Debt / Equity Ratio
9.95-3.901.851.041.290.74
Upgrade
Debt / EBITDA Ratio
2.10--2.293.3719.58
Upgrade
Debt / FCF Ratio
--7.822.30-5.54
Upgrade
Asset Turnover
2.001.661.551.561.702.01
Upgrade
Quick Ratio
0.700.560.831.061.041.07
Upgrade
Current Ratio
0.750.630.901.131.131.10
Upgrade
Return on Equity (ROE)
-154.52%-532.46%-77.70%6.63%5.78%-57.05%
Upgrade
Return on Assets (ROA)
-0.82%-14.31%-7.98%1.20%0.95%-6.19%
Upgrade
Return on Capital (ROIC)
-2.83%-46.11%-17.49%2.13%1.76%-17.78%
Upgrade
Earnings Yield
-0.54%-11.04%-8.00%0.53%0.25%-2.28%
Upgrade
FCF Yield
-2.59%-10.58%1.65%3.96%-3.45%0.75%
Upgrade
Buyback Yield / Dilution
-0.25%-0.04%4.37%2.84%-23.05%15.98%
Upgrade
Total Shareholder Return
-0.25%-0.04%4.37%2.84%-23.05%15.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.